Image of Stroke Prevention With the Angiotensin II Type 1-Receptor Blocker Candesartan in Elderly Patients With Isolated Systolic Hypertension

LITERATURE

Stroke Prevention With the Angiotensin II Type 1-Receptor Blocker Candesartan in Elderly Patients With Isolated Systolic Hypertension


In elderly patients with ISH, antihypertensive treatment based on the ARB candesartan resulted in a significant 42% RR reduction in stroke in comparison with other antihypertensive treatment, despite little difference in blood pressure reduction.


Availability

Canderin-003Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
J Am Coll Cardiol 2004;44:1175–80
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous